Hyperimmune bovine colostrum for treatment of GI infections

References

• Tzipori S, Roberton D, Chapman C. Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br Med J (Clin Res Ed) 1986; 293:1276 - 7; http://dx.doi.org/10.1136/bmj.293.6557.1276; PMID: 3096462
   PubMed Web of Science ®Google Scholar
• Tzipori S, Roberton D, Cooper DA, White L. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet 1987; 2:344 - 5; http://dx.doi.org/10.1016/S0140-6736(87)90944-5; PMID: 2886815
   PubMed Web of Science ®Google Scholar
• Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:348 - 54; http://dx.doi.org/10.1097/00042560-199612010-00008; PMID: 8948373
   PubMedGoogle Scholar
• Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 1998; 26:1324 - 9; http://dx.doi.org/10.1086/516374; PMID: 9636857
   PubMed Web of Science ®Google Scholar
• Tacket CO, Binion SB, Bostwick E, Losonsky G, Roy MJ, Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg 1992; 47:276 - 83; PMID: 1524140
   PubMed Web of Science ®Google Scholar
• Ashraf H, Mahalanabis D, Mitra AK, Tzipori S, Fuchs GJ. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial. Acta Paediatr 2001; 90:1373 - 8; http://dx.doi.org/10.1111/j.1651-2227.2001.tb01598.x; PMID: 11853331
   PubMedGoogle Scholar
• Opekun AR, El-Zaimaity HM, Osato MS, Gilger MA, Malaty HM, Terry M, et al. Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 1999; 13:35 - 42; http://dx.doi.org/10.1046/j.1365-2036.1999.00435.x; PMID: 9892877
   PubMed Web of Science ®Google Scholar
• Casswall TH, Sarker SA, Albert MJ, Fuchs GJ, Bergström M, Björck L, et al. Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther 1998; 12:563 - 8; http://dx.doi.org/10.1046/j.1365-2036.1998.00335.x; PMID: 9678817
   PubMedGoogle Scholar
• Hilpert H, Brüssow H, Mietens C, Sidoti J, Lerner L, Werchau H. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 1987; 156:158 - 66; http://dx.doi.org/10.1093/infdis/156.1.158; PMID: 3110303
   PubMed Web of Science ®Google Scholar
• Mitra AK, Mahalanabis D, Ashraf H, Unicomb L, Eeckels R, Tzipori S. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double-blind, controlled clinical trial. Acta Paediatr 1995; 84:996 - 1001; http://dx.doi.org/10.1111/j.1651-2227.1995.tb13814.x; PMID: 8652974
   PubMed Web of Science ®Google Scholar
• Davidson GP, Whyte PB, Daniels E, Franklin K, Nunan H, McCloud PI, et al. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 1989; 2:709 - 12; http://dx.doi.org/10.1016/S0140-6736(89)90771-X; PMID: 2570959
   PubMed Web of Science ®Google Scholar
• Turner RB, Kelsey DK. Passive immunization for prevention of rotavirus illness in healthy infants. Pediatr Infect Dis J 1993; 12:718 - 22; http://dx.doi.org/10.1097/00006454-199309000-00003; PMID: 8414797
   PubMedGoogle Scholar
• Tacket CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 1988; 318:1240 - 3; http://dx.doi.org/10.1056/NEJM198805123181904; PMID: 3283555
   PubMed Web of Science ®Google Scholar
• Freedman DJ, Tacket CO, Delehanty A, Maneval DR, Nataro J, Crabb JH. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis 1998; 177:662 - 7; http://dx.doi.org/10.1086/514227; PMID: 9498445
   PubMed Web of Science ®Google Scholar
• Otto W, Najnigier B, Stelmasiak T, Robins-Browne RM. Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scand J Gastroenterol 2011; 46:862 - 8; http://dx.doi.org/10.3109/00365521.2011.574726; PMID: 21526980
   PubMed Web of Science ®Google Scholar
• Tawfeek HI, Najim NH, Al-Mashikhi S. Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: a field trial. Int J Infect Dis 2003; 7:120 - 8; http://dx.doi.org/10.1016/S1201-9712(03)90007-5; PMID: 12839713
   PubMedGoogle Scholar
• Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 2009; 58:403 - 10; http://dx.doi.org/10.1016/j.jinf.2009.03.010; PMID: 19394704
   PubMed Web of Science ®Google Scholar
• Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15:573 - 81; http://dx.doi.org/10.1093/clind/15.4.573; PMID: 1420669
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55:Suppl 2 S88 - 92; http://dx.doi.org/10.1093/cid/cis335; PMID: 22752870
   PubMed Web of Science ®Google Scholar
• Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012; 55:216 - 23; http://dx.doi.org/10.1093/cid/cis386; PMID: 22491338
   PubMed Web of Science ®Google Scholar
• Johnson AP, Wilcox MH. Fidaxomicin: a new option for the treatment of Clostridium difficile infection. J Antimicrob Chemother 2012; 67:2788 - 92; http://dx.doi.org/10.1093/jac/dks302; PMID: 22865382
   PubMed Web of Science ®Google Scholar
• Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38:2386 - 8; PMID: 10835010
   PubMed Web of Science ®Google Scholar
• Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010; 74:309 - 18; http://dx.doi.org/10.1016/j.jhin.2009.10.016; PMID: 20153547
   PubMed Web of Science ®Google Scholar
• Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40:1591 - 7; http://dx.doi.org/10.1086/430315; PMID: 15889355
   PubMed Web of Science ®Google Scholar
• Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 2012; 50:4078 - 82; http://dx.doi.org/10.1128/JCM.02291-12; PMID: 23052318
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14:929 - 31; http://dx.doi.org/10.3201/eid1406.071447; PMID: 18507904
   PubMed Web of Science ®Google Scholar
• Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171:466 - 72; http://dx.doi.org/10.1503/cmaj.1041104; PMID: 15337727
   PubMed Web of Science ®Google Scholar
• Naaber P, Lehto E, Salminen S, Mikelsaar M. Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunol Med Microbiol 1996; 14:205 - 9; http://dx.doi.org/10.1111/j.1574-695X.1996.tb00288.x; PMID: 8856319
   PubMedGoogle Scholar
• Lyerly DM, Bostwick EF, Binion SB, Wilkins TD. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991; 59:2215 - 8; PMID: 2037383
   PubMed Web of Science ®Google Scholar
• Kelly CP, Chetham S, Keates S, Bostwick EF, Roush AM, Castagliuolo I, et al. Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrob Agents Chemother 1997; 41:236 - 41; PMID: 9021173
   PubMed Web of Science ®Google Scholar
• Warny M, Fatimi A, Bostwick EF, Laine DC, Lebel F, LaMont JT, et al. Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut 1999; 44:212 - 7; http://dx.doi.org/10.1136/gut.44.2.212; PMID: 9895380
   PubMed Web of Science ®Google Scholar
• Mattila E, Anttila VJ, Broas M, Marttila H, Poukka P, Kuusisto K, et al. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis 2008; 40:702 - 8; http://dx.doi.org/10.1080/00365540801964960; PMID: 19086244
   PubMed Web of Science ®Google Scholar
• Numan SC, Veldkamp P, Kuijper EJ, van den Berg RJ, van Dissel JT. Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut 2007; 56:888 - 9; http://dx.doi.org/10.1136/gut.2006.119016; PMID: 17519495
   PubMed Web of Science ®Google Scholar
• Wang H, Sun X, Zhang Y, Li S, Chen K, Shi L, et al. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect Immun 2012; 80:2678 - 88; http://dx.doi.org/10.1128/IAI.00215-12; PMID: 22615245
   PubMed Web of Science ®Google Scholar
• Steele J, Feng H, Parry N, Tzipori S. Piglet models of acute or chronic Clostridium difficile illness. J Infect Dis 2010; 201:428 - 34; http://dx.doi.org/10.1086/649799; PMID: 20039803
   PubMed Web of Science ®Google Scholar